Uterine activation is associated with increased oxytocin receptor (OXTR) expression and myometrial sensitivity to oxytocin. The OXTR promoter contains binding sites for CCAAT/enhancer-binding protein (CEBP) and nuclear factorkappa B p65 (RELA). RELA and CEBP beta (CEBPB) play a synergistic role in OXTR promoter activation. We created deletions in a DNA construct consisting of 850 bp upstream of the transcription start site linked to luc reporter to identify the CIS element of the OXTR promoter responsible for the synergistic activation by RELA and CEBPB. Deletion from À712 to À692 bp eliminated synergy, demonstrating that the critical region lies within these 20 bp. Binding studies showed that this sequence binds both RELA and CEBPB. The 20-bp critical region for synergistic activation of OXTR requires full-length RELA but only the basic leucine zipper domain of CEBPB.
INTRODUCTION
During pregnancy, the uterus is maintained in a quiescent state, but as labor approaches, it transforms to a contractile organ, highly sensitive to uterotonins and capable of the forceful contractions that characterize labor. Oxytocin and the oxytocin receptor (OXTR) play important roles in labor. Evidence in several species indicates a role of oxytocin in the expulsive phase of labor. Less supporting data are available for its role in the initiation of labor. Initial characterization of the oxytocin knockout mouse suggested that oxytocin is not needed for initiation or progress of labor [1] ; however, subsequent investigations suggested that oxytocin is important for the precise timing of the onset of labor [2] . In the human, oxytocin antagonists are not effective in inhibition of spontaneous contractions at term [3] . Although circulating oxytocin concentration does not rise with the onset of labor, the term human pregnant uterus displays increased sensitivity to infused oxytocin. One of the most important and consistent findings of uterine activation is the marked increase in OXTR mRNA and protein [4] expression, contributing to increased myometrial sensitivity to oxytocin at term. OXTR expression has also been demonstrated in human amnion [5] and has been shown to increase dramatically with the onset of labor in the rabbit amnion [6] .
Both preterm and term labor are characterized by an influx of inflammatory cells, such as neutrophils and macrophages, into the uterus [7] and increased expression of proinflammatory cytokines and chemokines [8] . An associated increase in the baseline level of nuclear factor-kappa B (NFKB) DNA-binding and transcriptional activity also occurs in human amnion [9] . Basal and interleukin (IL) 1B-induced NFKB DNA binding involves the p50-p65 heterodimers as well as p65 and p50 homodimers [10] . Condon et al. [11] have demonstrated an increase in NFKB activity in fundal, laboring myometrium in both human and mouse.
The OXTR promoter contains 10 CCAAT/enhancer-binding protein (CEBP), three NFKB, and five activatory protein 1 putative transcription factor-binding sites. In a previous report [12] , we demonstrated the presence of each of these transcription factors in myometrial tissue before and after the onset of labor using Western blot analysis. Overexpression of both NFKB p65 (RELA) and CEBP beta (CEBPB) increased OXTR promoter activity, whereas overexpression of activatory protein 1 did not. However, the combination of RELA and CEBPB together resulted in a dramatically enhanced upregulation of promoter activity. Coimmunoprecipitation experiments demonstrated a physical interaction between RELA and CEBPB.
Our initial studies introduced deletions and truncations into the OXTR promoter, and we determined that the synergistic effect was not mediated by any previously identified NFKB or CEBP DNA-binding site but, rather, by a 195-bp region of the OXTR promoter, which lies between À656 and À850 bp from the transcription start site (TSS). We now report that we have narrowed down the DNA region responsible for synergistic upregulation of the OXTR promoter by RELA and CEBPB to a 20-bp sequence (Fig. 1 ). This previously unrecognized sequence binds both RELA and CEBPB in vitro. Chromatin immunoprecipitation (ChIP) studies show that binding of both transcription factors to that sequence is increased by IL1B.
MATERIALS AND METHODS

Cell Culture
Myometrial cells were extracted from biopsy specimens taken at the time of elective cesarean section at term with the approval of the Ethics Committee of the Imperial College London and patient consent. None of the patients was in 
Site-Directed Mutagenesis
The mutation of individual base pairs in plasmid DNA was achieved using the QuikChange Site-Directed Mutagenesis Kit (Stratagene) according to manufacturer's instructions. This involves the construction of complementary oligonucleotides of approximately 20 bp spanning the region of interest. These oligos incorporate changes in base pairs necessary to alter the sequence and were used in a PCR reaction including 103 reaction buffer, 10 mM each dNTP, 10 ng of template DNA, and 2.5 U of PfuTurbo DNA polymerase in a total volume of 50 ll. The reaction mixture was heated to 958C for 30 sec followed by annealing at 558C for 1 min with extension at 688C for 20 min and repeated for 18 cycles. Following the PCR, the reaction was treated with DpnI for 1 h at 378C to remove the template (this enzyme digests methylated DNA and is used to selectively digest the plasmid DNA template) and transformed, in parallel with a control PCR that has not been treated with DpnI, into Escherichia coli XL1 Blue chemically competent cells. The success of the mutagenesis was initially determined by observing the plates for colony growth. Ideally, there should be large number of colonies on the non-DpnI-treated DNA plate and fewer on the DpnI-treated one. DNA from candidate colonies was then isolated by mini-prep and sequenced to verify the presence of the appropriate mutation. The mutagenic oligonucleotide primers were designed individually and are shown in Table 1 .
Cloning RELA and CEBPB Domains
Expression constructs for two RELA and two CEBPB domains were cloned using available bioinformatics information using full-length constructs as template. The primer pairs used and the start and end sites for each construct are shown in Table 2 . The PCR products were cloned into the BamHI and BglII sites in the pSG5 vector.
Transient Transfections
Myocytes were grown in 24-well plates to 80% confluence. Transient transfections were performed using FuGENE 6 Transfection Reagent (Roche). Cytomegalovirus-Renilla vector (1:10 dilution) was used to control for transfection efficiency and cell number. A luciferase reporter vector containing the 850 bp of the OXTR promoter upstream of the TSS was used as previously described [12] . Expression constructs for CEBPB and RELA were FIG. 1. Schematic design of putative transcription factor-binding sites for NFKB and CEBP on the OXTR promoter. Initial studies determined that the synergistic effect of RELA and CEBPB on the OXTR promoter was mediated by a 195-bp region of the OXTR promoter, between À656 and À850 bp from the TSS. In the present study, the DNA region responsible for synergistic up-regulation of the OXTR promoter by RELA and CEBPB is narrowed down to a 20-bp sequence, between À712 and À692 from the TSS. 
Construct
Forward primer sequence Reverse primer sequence 
Transfection of myocytes with the RELA expression vector increases the RELA expression but has no effect upon CEBPB expression. Similarly, overexpression of CEBPB increases the CEBPB protein expression, whereas the RELA level remains unchanged.
made using a basic pSG5 vector and cotransfected at 0.2 lg/well. The empty expression vector pSG5 was included as a filler construct when required so that the total amount of transfected DNA per well was constant. Cells were cultured for a total of 48 h, followed by harvesting and analysis with a dual firefly/Renilla luciferase assay (Luclite; Packard Bell) and Coelentrerazin (CNBiosciences).
Electrophoretic Mobility Shift Assay
For electrophoretic mobility shift assay (EMSA), nuclear protein extract (3 lg) was incubated on ice for 1 h with nonradiolabeled (cold) specific competitive and nonspecific competitive (Oct-1) oligonucleotide (1.75 pmol) in binding buffer with polydeoxyinosinic-polydeoxycytidylic acid to minimize nonspecific binding (4% glycerol, 1 mM MgCl 2 , 0.4 mM ethylenediaminetetraacetic acid, 10 mM Tris-HCl, 50 mM NaCl, and 0.4 mM dithiothreitol), then incubated for 45 min on ice with [ 32 P]ATP end-labeled oligonucleotide probe. Nonradiolabeled oligonucleotides were at 200-fold excess to the 32 P-labeled probes for specific and nonspecific competitions for DNA binding. The resulting protein-DNA complexes were separated in a 4% acrylamide gel run at 250 V for 1 h. The gel was dried under vacuum for 1 h at 808C and exposed to x-ray film. For supershift analysis, samples were incubated with 2 lg of antibodies (Santa Cruz) for 30 min on ice before incubation with oligonucleotides.
ChIP Assay
The DNA-protein complexes were cross-linked in situ with 1% formaldehyde. The cells were lysed, and chromatin was sheared into 200-to 1000-bp fragments by sonication. Antibodies recognizing the C-terminal of RELA (Santa Cruz Biotechnology), CEBPB (Santa Cruz Biotechnology), and   FIG. 3 . Schematic of the deletion constructs made in the OXTR promoter in the first series of experiments (a) and within the OTR D4 region in the second series of experiments (c). The sequence shown is the deleted region. Transient transfections of primary myocytes were performed using these deletion constructs of OXTR promoter and cotransfected with expression vectors for RELA, CEBPB, or both. The deletion OTR D4 eliminated synergy (b), and further deletion within the OTR D4 region showed that synergy depended upon the sequence OTR D4B (d). Results are expressed as the fold-increase of luciferase/Renilla ratio (mean 6 SEM, n ¼ 6; *P , 0.05).
acetyl-histone H4 (Upstate Cell Signaling Solutions) were used for immunoprecipitation, and the chromatin fragments containing the cross-linked protein were purified by immunoabsorption and elution from protein A/G beads (Santa Cruz Biotechnology). The cross-links were reversed, and the DNA was purified using a QIAquick Nucleotide Removal Kit (QIAGEN). The DNA region crosslinked to the protein was determined by PCR analysis, and primers were designed to amplify 151 bp of the OXTR promoter (À744 to À593 bp from the TSS). The primer sequences were 5 0 -TGGGGCTGTAATTGTGGATT-3 0 and 3 0 -AAAAAGGCCAGGATTCAAAAA-5 0 . Positive control was input DNA, and the negative control was immunoglobulin (Ig) G-precipitated DNA.
Western Blot Analysis
Protein samples were denatured by boiling for 5 min and run on a 10% SDS-PAGE for 60 min at 140 V, followed by a transfer to a Hybond ECL nitrocellulose membrane (Amersham Pharmacia Biotech). The membrane was blocked in 5% milk protein solution overnight or for 1 h, then washed and hybridized with the primary antibody for 1 h at room temperature in a fresh blocking buffer (13 PBS, 1% milk protein, and 0.1% Tween-20) containing antibodies for RELA, CEBPB, or beta-actin (Santa Cruz Biotechnology). This process was repeated with the secondary antibody. For enhanced chemiluminescence detection of horseradish peroxidase, ECL Plus (Amersham Biosciences) was used. Exposure for detection was at 258C for 5 min.
Statistical Analysis
Transfection data are expressed as the mean 6 SEM. Statistical analysis was performed by ANOVA, with the level of significance defined as P , 0.05.
RESULTS
Overexpression of RELA Does Not Increase Expression of CEBPB or Vice Versa
Our previous data showed that overexpression of either RELA or CEBPB caused increased activity of OXTR promoter but that the combination of both caused a much larger increase [12] . To ensure that overexpression of RELA did not increase expression of CEBPB or vice versa, Western blot analysis was performed using protein extracts from cells in which either RELA or CEBPB had been overexpressed. RELA was expressed in control myocytes; its expression was increased by transfection of the RELA expression vector but was unaffected by transfection of the CEBPB expression vector. CEBPB was expressed at much lower levels in control cells; its expression was increased by transfection of the CEBPB expression vector but was unaffected by transfection of the RELA expression vector (Fig. 2) . Two bands were detected at the corresponding molecular weight, similar to the manufacturer's published control Western blot (CEBPB [H-7] : sc-7962; Santa Cruz Biotechnology).
The CIS Element of the OXTR Promoter that Confers the Potential for Synergistic Activation by RELA and CEBPB Lies Within the 20-bp Region Between À792 and À712 bp
To identify the CIS element of the OXTR promoter that confers the potential for synergistic activation by RELA and CEBPB, we created deletions in a DNA construct consisting of 850 bp upstream of the TTS linked to a luc reporter in the vector pGL3. These deletions removed 34, 38, 42, 39, and 37 bp sequentially from the previously identified 196-bp response region (Fig. 3a) , preserving the remainder of the promoter sequence intact. Each new construct was transfected into primary myometrial cells in culture with expression vectors for CEBPB, RELA, or both. Deletions from À846 to À811, À811 to À773, À773 to À731, and À692 to À655 bp did not affect the synergistic response of the OXTR promoter to RELA and CEBPB, whereas a 39-bp deletion from À731 to À692 bp eliminated the synergy (Fig. 3b) .
We next created two further deletion constructs from À734 to À712 bp and from À712 to À692 bp (Fig. 3c) . These constructs were then used in similar transfection experiments. Deletion from À734 to À712 bp preserved the synergy, whereas deletion from À712 to À692 bp eliminated the synergy, demonstrating that the critical region lies within the 20 bp from À712 to À692 bp from the TSS (Fig. 3d) . The online computer-based sequence analysis TFSEARCH (http:// www.cbrc.jp/research/db/TFSEARCH.html) used in our previous study had not identified any NFKB-or CEBP-binding sites in this region. However, using the search engine TESS (http:// www.cbil.upenn.edu/cgi-bin/tess/tess), we identified one putative CEBPB-binding site in the region from À711 to À695 bp. 1-5) . Specificity of RELA and CEBPB binding is confirmed by coincubation with nonlabeled, noncompeting (Oct-1 consensus) and nonlabeled, competing (OTR D4B region) oligonucleotide. Coincubation with antibodies to RELA and CEBPB leads to band intensity reduction. Myometrial nuclear protein also binds to consensus DNA-binding sequences for NFKB (a; lanes 7-10) and CEBP (a; lanes [12] [13] [14] [15] . Coincubation with antibodies to RELA and CEBPB leads to band supershift. ChIP analysis demonstrates the in vivo binding of RELA and CEBPB to the region of the OXTR promoter, which includes OTR D4B (b).
33-bp oligonucleotide sequence (À712 to À679 bp), which contained the 20-bp region responsible for the synergistic activation of the OXTR promoter together with control consensus DNA-binding sequences for NFKB and CEBP. Specific RELA and CEBPB binding was seen to all three DNA sequences. Preincubation of the NFKB control consensus DNA-binding sequence with antibodies to RELA or of the CEBP control consensus DNA-binding sequence with antibodies to CEBPB caused band supershift, as would be expected. However, preincubation with antibodies to RELA or CEBPB with the OXTR-specific, 33-bp oligonucleotide sequence led not to supershift but, rather, to elimination of DNA binding for both RELA and CEBPB (Fig. 4a) . The likelihood is that supershift antibodies, bound to either RELA or CEBPB, lead to disruption of their interaction and therefore inhibit DNA binding.
To demonstrate that RELA and CEBPB bind in vivo to the critical region, ChIP analysis was performed using PCR primers, amplifying the region from À744 to À593 bp. This confirmed increased in vivo binding of RELA and CEBPB to this region of the OXTR promoter following stimulation with IL1B (Fig. 4b) .
To identify the regions of RELA and CEBPB involved in the synergistic activation of OXTR promoter, we created expression vectors for two truncated protein sequences from each of RELA and CEBPB. Coexpression of full-length RELA with only the basic leucine zipper (bZIP; DNA-binding and dimerization domain) region of CEBPB resulted in preservation of the synergistic effect on OXTR activity. Coexpression of full-length RELA with a CEBPB sequence lacking the bZIP region was not synergistic. This suggests that only the DNAbinding and dimerization domain region of CEBPB is required for synergy. Synergy requires full-length RELA, because coexpression of the full-length CEBPB sequence with RELA lacking either the activation or the Rel homology regions eliminated the synergistic effect (Fig. 5) .
DISCUSSION
Both NFKB and CEBP are important transcription factor families that are involved in immune and inflammatory functions as well as in cell growth and differentiation. Synergy between CEBPB and NFKB plays a role in the expression of IL6 and IL8 genes [13] [14] [15] , CRP [16] , and the serum-amyloid alpha gene [17, 18] . Increased OXTR expression contributes to the increased myometrial sensitivity to oxytocin at term. Recent data suggest that OXTR may be considered as a member of the family of acute-phase response genes, regulated by cytokines via the inflammatory transcription factors NFKB and CEBP [12] .
The present findings further support the role of RELA and CEBPB in regulation of OXTR and show that a 20-bp sequence of the OXTR promoter is critical for the synergistic activation of the promoter by RELA and CEBPB. This novel 20-bp region of the OXTR promoter most closely resembles a consensus CEBP but not a NFKB DNA-binding site. It therefore is likely that CEBPB primarily binds to this part of the OXTR promoter but also directly interacts with RELA. Both RELA and CEBPB can physically bind together, and it has been suggested that this involves the bZIP region of CEBPB [14] and regions in the Rel homology and activation domain of RELA [19] .
The EMSA studies using consensus or sequence-specific NFKB and CEBP sites of the OXTR promoter demonstrate specific DNA binding and supershift with antibodies both for CEBPB and for RELA [12] . However, EMSA performed using a 33-bp oligonocleotide sequence (À712 to À679 bp) containing the 20-bp region responsible for the synergistic activation of the OXTR promoter incubated with antibodies leads not to supershift but, rather, to inhibition of binding. Considering that only a putative CEBP-binding site is found in this region and not a NFKB-binding site, this suggests that the antibodies inhibit the interaction between CEBPB and RELA, therefore inhibiting either their binding to each other or their binding to DNA.
The ChIP analysis supports the concept that IL1B leads to binding of RELA and CEBPB to the 20-bp critical region; however, ChIP assays have inherent limitations. These assays cannot target and isolate a DNA region as small as 20 bp, because the size of the sheared cross-linked DNA region cannot be smaller than 200 bp. The ChIP data alone are FIG. 5 . Schematic diagram showing the expression vectors made for RELA activation domain and Rel homology region and a construct expressing the CEBPB bZIP region and a CEBPB construct lacking the bZIP region (a, EMSA; b, ChIP). The effects of the various RELA and CEBPB expression constructs on the OXTR promoter activity are also shown (c). Full-length RELA is needed to maintain the synergistic up-regulation of the OXTR alongside CEBPB, whereas only the bZIP domain of the CEBPB is enough to conserve the synergy. Results are expressed as the fold-increase of luciferase/Renilla ratio (mean 6 SEM, n ¼ 6; *P , 0.05).
therefore supportive but not conclusive. Data from the studies using truncated sequences of CEBPB and RELA support the concept that the function of CEBPB in this complex is to bind DNA and RELA, because the relatively small bZIP region, which contains both the DNA-binding and dimerization domains but not the activation domain or, indeed, any of the other domains in the protein, is sufficient for the synergistic effect. Both the Rel homology region, which mediates dimerization, and the activation domains of RELA, which are at opposite ends of the protein, are required or the synergistic effect showing that the full molecule participates in the activation of OXTR promoter.
The increase in myometrial IL1B, IL6, and tumor necrosis factor-alpha expression associated with labor activates the NFKB and CEBP transcription factor systems, providing a plausible mechanism by which OXTR may be up-regulated with labor. It is probable that interaction between RELA and CEBPB plays a role in the regulation of other genes involved in the labor process. For example, the cytokine IL8 plays a role in cervical remodeling [20, 21] , and it has been shown to be upregulated by the interaction between RELA and CEBPB [15] . Understanding common regulatory pathways for the full range of ''labor-associated genes'' may provide the basis for novel and more efficient pharmacotherapeutic approaches to prevent preterm delivery.
